By Ben Hansel, Senior Financial Editor 247MarketNews
DENVER, Colo. (247MarketNews) — Glass House Brands (NYSE:GLAS) delivered a substantial production increase in the third quarter of 2026, as revenue reached $56.8 million, up from $26.2 million in the third quarter of 2025 and $47 million in the previous quarter. The company also reported record equivalent dry-pound production of 319,052 pounds, a 30% increase from Q2 and approximately 157% above the year-ago period.
Perhaps more important, Glass House reduced its reported production cost to $109 per pound, down from $122 in Q2 and $175 in Q1. Management continues to target a long-term production cost of $95 per pound, suggesting there may be additional room for operational improvement if the company can sustain its progress.
However, the results also illustrate the difficult economics of producing cannabis at scale. The average selling price for biomass dropped to $151 per pound from $211 in Q2, a decline of approximately 28%. Gross margin consequently fell to 26% from 34% in the previous quarter, despite higher production and revenue.
That pricing pressure is particularly important because wholesale biomass generated approximately $50 million, or 88% of quarterly revenue. Glass House is therefore heavily exposed to wholesale cannabis pricing, making production efficiency and the ability to secure attractive sales contracts critical to its financial performance.
Regulatory Positioning and the Next Growth Opportunity
Beyond the quarterly numbers, Glass House is positioning itself for potential changes in the U.S. cannabis regulatory environment. CEO Kyle Kazan says the company is already registered with the DEA and operates its medical business under a Schedule III designation. Management believes this structure could allow Glass House to benefit from developments in medical cannabis regulation without relying exclusively on broader recreational cannabis rescheduling.
The company has also reported Good Agricultural and Collection Practice (GACP) certifications for its Casitas and Padaro farms, an important preparatory step toward potential international medical cannabis distribution. Management says it is exploring supply and distribution arrangements while working with California regulators on a tracking system for out-of-state and international sales.
The company’s recent milestones also include its first international hemp sale, the hiring of a former DEA compliance executive to advise on interstate commerce and export opportunities, and its move to the New York Stock Exchange. These developments point toward a strategy extending beyond simply increasing California production.
Financing, Margins and the Next Catalysts
There are also financial considerations investors should not overlook. Glass House ended September with $39.7 million in cash and restricted cash, compared with $22.1 million at the end of Q2. During the quarter, it raised approximately $18 million through its at-the-market (ATM) offering at an average share price of $8.11 and received another $10 million from warrant exercises.
Those financing proceeds support facility expansion, automation and production improvements, but the capital structure deserves attention. The company reported approximately $69.2 million in notes payable and $92.1 million in preferred equity at quarter-end. Its Series D and Series E preferred securities carry annual dividend rates of 15% and 12%, respectively, representing a meaningful ongoing financial obligation.
The next milestones to watch include fourth-quarter production costs, progress toward the approximately one-million-pound full-year production forecast, the planned reduction toward $95-per-pound production costs, and concrete developments in medical cannabis export opportunities.
About the Author
Ben Hansel is a financial and business writer with a background in business, sales, and finance. He graduated from the University of Texas at El Paso. His professional and educational background informs his coverage of financial markets, corporate developments, economic trends and the broader forces shaping the market.
Important Editorial Note: 247MarketNews highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.